Silence plans share placement

Biotech company Silence Therapeutics has unveiled plans for an up-to £6.5m share placing to fund the continued development of two potentially breakthrough treatments for cancer. The placing of 275m shares at 2p each is being underwritten by Singer Capital Markets.